Jefferies Downgrades BioLife Solutions to Hold, Raises Price Target to $31

Benzinga Newsdesk www.benzinga.com Negative 88.6%

Neg 88.6% Neu 0% Pos 0%

Jefferies analyst Matthew Stanton downgrades BioLife Solutions (NASDAQ:BLFS) from Buy to Hold and raises the price target from $30 to $31.